المؤلفون: Tahereh Motallebirad, Hossein Fazeli, Ataollah Ghahiri, Dariush Shokri, Saba Jalalifar, Sharareh Moghim, Bahram Nasr Esfahani

المصدر: BMC Microbiology, Vol 21, Iss 1, Pp 1-11 (2021)

مصطلحات موضوعية: Streptococcus agalactiae, Capsular genotyping, Pilus islands, Antibiotic susceptibility, MLST, Iran, Microbiology, QR1-502

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2180

URL الوصول: https://doaj.org/article/71f358d338c14c7a8cabefec26d1a4b9

المؤلفون: Motallebirad, Tahereh, Fazeli, Hossein, Ghahiri, Ataollah, Shokri, Dariush, Jalalifar, Saba, Moghim, Sharareh, Esfahani, Bahram Nasr^Aff1

المصدر: BMC Microbiology. 21(1)

المؤلفون: Mousavi, Seyed Masoud, Nasaj, Mona, Hosseini, Seyed Mostafa, Arabestani, Mohammad Reza

المصدر: GMS Hygiene and Infection Control, Vol 11, p Doc18 (2016)

مصطلحات موضوعية: Streptococcus agalactiae, group B streptococci, capsular genotyping, polymerase chain reaction, antibiotic susceptibility, macrolide-lincosamide-streptogramin B, Medicine, Public aspects of medicine, RA1-1270, Microbiology, QR1-502

وصف الملف: electronic resource

Relation: http://www.egms.de/static/en/journals/dgkh/2016-11/dgkh000278.shtml; https://doaj.org/toc/2196-5226

URL الوصول: https://doaj.org/article/2412995f89894565b740c983dc923c45

المؤلفون: Tomislav Kostyanev, L. Setchanova, Vesela Ouzounova-Raykova, Y. Proevska, Ivan Mitov

المصدر: Journal of IMAB, Vol 16, Iss 3, Pp 66-69 (2010)

مصطلحات موضوعية: H. influenzae, capsular genotyping, non-typeable H. influenzae, beta-lactamase, Dentistry, RK1-715, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://www.journal-imab-bg.org/statii-10/vol16_b3_p66-69.pdf; https://doaj.org/toc/1312-773X

URL الوصول: https://doaj.org/article/027ecd0a8bae41818779c93572d7f399

المؤلفون: Saba Jalalifar, Sharareh Moghim, Bahram Nasr Esfahani, Dariush Shokri, Hossein Fazeli, Tahereh Motallebirad, Ataollah Ghahiri

المصدر: BMC Microbiology
BMC Microbiology, Vol 21, Iss 1, Pp 1-11 (2021)

مصطلحات موضوعية: Microbiology (medical), Serotype, Antibiotic susceptibility, Erythromycin, Biology, Iran, medicine.disease_cause, Microbiology, Group B, Pilus islands, Streptococcus agalactiae, 03 medical and health sciences, Antibiotic resistance, Capsular genotyping, Pregnancy, Streptococcal Infections, Genotype, Drug Resistance, Bacterial, medicine, Prevalence, Humans, Serotyping, 030304 developmental biology, 0303 health sciences, 030306 microbiology, Streptococcus, Research, QR1-502, Anti-Bacterial Agents, Genes, Bacterial, Fimbriae, Bacterial, Multilocus sequence typing, Female, medicine.drug, MLST

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876cb31e42a0eee2988dea02565eac01
https://pubmed.ncbi.nlm.nih.gov/33947330

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Maria José Borrego, Carlos Florindo, Silvia Viegas, E. Rodrigues, Albertina Paulino, João Paulo Gomes

المصدر: Clinical Microbiology and Infection. (9):1458-1463

مصطلحات موضوعية: Microbiology (medical), Molecular epidemiology, Portugal, Antibiotic resistance, capsular genotyping, Erythromycin, General Medicine, Drug resistance, Biology, medicine.disease_cause, Virology, Microbiology, Streptococcus agalactiae, Infectious Diseases, Capsular genotyping, Transmissão vertical, Genotype, medicine, Multilocus sequence typing, Infecções Sexualmente Transmissíveis, medicine.drug, Antibacterial agent, MLST

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d90b4bdf862b9a3fb49f123ceb0f8f3

عناروين إضافية: Untersuchung der Verteilung und des Antibiotikaresistenzprofils klinischer Isolate von Gruppe-B-Streptokokken (Streptococcus agalactiae)

المصدر: GMS Hygiene and Infection Control; VOL: 11; DOC18 /20160912/

مصطلحات الفهرس: Streptococcus agalactiae, group B streptococci, capsular genotyping, polymerase chain reaction, antibiotic susceptibility, macrolide-lincosamide-streptogramin B, Gruppe-B-Streptococci, Genotypisierung, Polymerase-Kettenreaktion, antibiotische Empfindlichkeit, Macrolid-Lincosamid-Streptogramin B, ddc: 610, article

URL: http://nbn-resolving.de/urn:nbn:de:0183-dgkh0002780
http://www.egms.de/en/journals/dgkh/2016-11/dgkh000278.shtml
Acikgoz ZC, Almayanlar E, Gamberzade S, Gocer S. Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital. Antimicrob Agents Chemother. 2004 Apr;48(4):1410-2. DOI: 10.1128/AAC.48.4.1410-1412.2004
Arpin C, Daube H, Tessier F, Quentin C. Presence of mefA and mefE genes in Streptococcus agalactiae. Antimicrob Agents Chemother. 1999 Apr;43(4):944-6.
Back EE, O'Grady EJ, Back JD. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital. Antimicrob Agents Chemother. 2012 Feb;56(2):739-42. DOI: 10.1128/AAC.05794-11
Bergseng H, Afset JE, Radtke A, Loeseth K, Lyng RV, Rygg M, Bergh K. Molecular and phenotypic characterization of invasive group B streptococcus strains from infants in Norway 2006-2007. Clin Microbiol Infect. 2009 Dec;15(12):1182-5. DOI: 10.1111/j.1469-0691.2009.02789.x
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI document M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.
Dahesh S, Hensler ME, Van Sorge NM, Gertz RE Jr, Schrag S, Nizet V, Beall BW. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother. 2008 Aug;52(8):2915-8. DOI: 10.1128/AAC.00461-08
De Azavedo JC, Yeung RH, Bast DJ, Duncan CL, Borgia SB, Low DE. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother. 1999 Sep;43(9):2144-7.
Desjardins M, Delgaty KL, Ramotar K, Seetaram C, Toye B. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol. 2004 Dec;42(12):5620-3. DOI: 10.1128/JCM.42.12.5620-5623.2004
Dipersio LP, Dipersio JR. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus. Diagn Microbiol Infect Dis. 2007 Feb;57(2):189-93. DOI: 10.1016/j.diagmicrobio.2006.07.013
Dutra VG, Alves VM, Olendzki AN, Dias CA, de Bastos AF, Santos GO, de Amorin EL, Sousa MÂ, Santos R, Ribeiro PC, Fontes CF, Andrey M, Magalhães K, Araujo AA, Paffadore LF, Marconi C, Murta EF, Fernandes PC Jr, Raddi MS, Marinho PS, Bornia RB, Palmeiro JK, Dalla-Costa LM, Pinto TC, Botelho AC, Teixeira LM, Fracalanzza SE. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis. 2014;14:323. DOI: 10.1186/1471-2334-14-323
de-Paris F, Machado AB, Gheno TC, Ascoli BM, Oliveira KR, Barth AL. Group B Streptococcus detection: comparison of PCR assay and culture as a screening method for pregnant women. Braz J Infect Dis. 2011 Jul-Aug;15(4):323-7. DOI: 10.1016/S1413-8670(11)70199-4
El Aila NA, Tency I, Claeys G, Saerens B, De Backer E, Temmerman M, Verhelst R, Vaneechoutte M. Genotyping of Streptococcus agalactiae (group B streptococci) isolated from vaginal and rectal swabs of women at 35-37 weeks of pregnancy. BMC Infect Dis. 2009;9:153. DOI: 10.1186/1471-2334-9-153
Emaneini M, Mirsalehian A, Beigvierdi R, Fooladi AA, Asadi F, Jabalameli F, Taherikalani M. High Incidence of Macrolide and Tetracycline Resistance among Streptococcus Agalactiae Strains Isolated from Clinical Samples in Tehran, Iran. Maedica (Buchar). 2014 Jun;9(2):157-61.
Florindo C, Viegas S, Paulino A, Rodrigues E, Gomes JP, Borrego MJ. Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family. Clin Microbiol Infect. 2010 Sep;16(9):1458-63. DOI: 10.1111/j.1469-0691.2009.03106.x
Gaudreau C, Lecours R, Ismal J, Gagnon S, Jetté L, Roger M. Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J Antimicrob Chemother. 2010 Mar;65(3):594-5. DOI: 10.1093/jac/dkp458
Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, Orefici G, Dicuonzo G, Creti R. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol. 2007 Sep;45(9):2909-16. DOI: 10.1128/JCM.00999-07
Granlund M, Axemo P, Bremme K, Bryngelsson AL, Carlsson Wallin M, Ekström CM, Håkansson S, Jacobsson B, Källén K, Spetz E, Tessin I; Swedish Working Group for the Prevention of Perinatal Group B Streptococcal Infections. Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program. Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1195-201. DOI: 10.1007/s10096-010-0877-3
Gygax SE, Schuyler JA, Kimmel LE, Trama JP, Mordechai E, Adelson ME. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother. 2006 May;50(5):1875-7. DOI: 10.1128/AAC.50.5.1875-1877.2006
Heelan JS, Hasenbein ME, McAdam AJ. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol. 2004 Mar;42(3):1263-4. DOI: 10.1128/JCM.42.3.1263-1264.2004
Janapatla RP, Ho YR, Yan JJ, Wu HM, Wu JJ. The prevalence of erythromycin resistance in group B streptococcal isolates at a University Hospital in Taiwan. Microb Drug Resist. 2008 Dec;14(4):293-7. DOI: 10.1089/mdr.2008.0853
Jannati E, Roshani M, Arzanlou M, Habibzadeh S, Rahimi G, Shapuri R. Capsular serotype and antibiotic resistance of group B streptococci isolated from pregnant women in Ardabil, Iran. Iran J Microbiol. 2012 Sep;4(3):130-5.
Kimura K, Suzuki S, Wachino J, Kurokawa H, Yamane K, Shibata N, Nagano N, Kato H, Shibayama K, Arakawa Y. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother. 2008 Aug;52(8):2890-7. DOI: 10.1128/AAC.00185-08
Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013 Aug;31 Suppl 4:D31-42. DOI: 10.1016/j.vaccine.2013.05.012
Nagano N, Nagano Y, Toyama M, Kimura K, Tamura T, Shibayama K, Arakawa Y. Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J Antimicrob Chemother. 2012 Apr;67(4):849-56. DOI: 10.1093/jac/dkr546
Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ; Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008 May;299(17):2056-65. DOI: 10.1001/jama.299.17.2056
Seo YS, Srinivasan U, Oh KY, Shin JH, Chae JD, Kim MY, Yang JH, Yoon HR, Miller B, DeBusscher J, Foxman B, Ki M. Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci. 2010 Jun;25(6):817-23. DOI: 10.3346/jkms.2010.25.6.817